These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35722497)

  • 1. Occurrence of Thromboembolism in Paediatric Patients With Inflammatory Bowel Disease: Data From the CEDATA-GPGE Registry.
    De Laffolie J; Ballauff A; Wirth S; Blueml C; Rommel FR; Claßen M; Laaß M; Lang T; Hauer AC;
    Front Pediatr; 2022; 10():883183. PubMed ID: 35722497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA-GPGE Registry.
    Elonen L; Wölfle L; de Laffolie J; Posovszky C;
    Front Pediatr; 2022; 10():875938. PubMed ID: 35712614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry.
    Buderus S; Scholz D; Behrens R; Classen M; De Laffolie J; Keller KM; Zimmer KP; Koletzko S;
    Dtsch Arztebl Int; 2015 Feb; 112(8):121-7. PubMed ID: 25759978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolism is associated with poor prognosis and high mortality in patients with inflammatory bowel disease: A case-control study.
    S Y; Kedia S; Teja V; Vuyyuru SK; Yadav N; Sahu P; Jain S; Yadav DP; Bopanna S; Mouli VP; Madhu D; Sharma R; Das P; Makharia G; Ahuja V
    Indian J Gastroenterol; 2022 Aug; 41(4):325-335. PubMed ID: 36063357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of the Porto criteria for the diagnosis of paediatric inflammatory bowel disease in a paediatric reference centre].
    Martín de Carpi J; Vila V; Varea V
    An Pediatr (Barc); 2011 Oct; 75(4):232-8. PubMed ID: 21549650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry.
    Aardoom MA; Klomberg RCW; Kemos P; Ruemmele FM; ; van Ommen CHH; de Ridder L; Croft NM;
    J Crohns Colitis; 2022 Jun; 16(5):695-707. PubMed ID: 34599822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic delay in children with inflammatory bowel disease in the German-Austrian patient registry CEDATA-GPGE 2014-2018.
    Leiz M; Knorr M; Moon K; Tischler L; de Laffolie J; van den Berg N
    Sci Rep; 2022 Dec; 12(1):21162. PubMed ID: 36477258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.
    Dhaliwal J; Walters TD; Mack DR; Huynh HQ; Jacobson K; Otley AR; Debruyn J; El-Matary W; Deslandres C; Sherlock ME; Critch JN; Bax K; Seidman E; Jantchou P; Ricciuto A; Rashid M; Muise AM; Wine E; Carroll M; Lawrence S; Van Limbergen J; Benchimol EI; Church P; Griffiths AM
    J Crohns Colitis; 2020 May; 14(4):445-454. PubMed ID: 31136648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease.
    Zitomersky NL; Levine AE; Atkinson BJ; Harney KM; Verhave M; Bousvaros A; Lightdale JR; Trenor CC
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):343-7. PubMed ID: 23752078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
    Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local thrombolysis: a newer approach to treating inflammatory bowel disease-related thromboembolism.
    Tabibian JH; Roth BE
    J Clin Gastroenterol; 2009; 43(5):391-8. PubMed ID: 19247203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry.
    Kovacs M; Muller KE; Arato A; Lakatos PL; Kovacs JB; Varkonyi A; Solyom E; Polgar M; Nemes E; Guthy I; Tokodi I; Toth G; Horvath A; Tarnok A; Tomsits E; Csoszánszky N; Balogh M; Vass N; Bodi P; Dezsofi A; Gardos L; Micskey E; Papp M; Szucs D; Cseh A; Molnar K; Szabo D; Veres G;
    J Crohns Colitis; 2012 Feb; 6(1):86-94. PubMed ID: 22261532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of exclusive enteral nutrition in pediatric patients with Crohn's disease-results of a survey of CEDATA-GPGE reporting centers.
    Peters S; Cantez S; De Laffolie J;
    Mol Cell Pediatr; 2022 Apr; 9(1):6. PubMed ID: 35381916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?
    Miehsler W; Reinisch W; Valic E; Osterode W; Tillinger W; Feichtenschlager T; Grisar J; Machold K; Scholz S; Vogelsang H; Novacek G
    Gut; 2004 Apr; 53(4):542-8. PubMed ID: 15016749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year prospective registry of inflammatory bowel disease in the Argentine pediatric population.
    Vicentín R; Wagener M; Pais AB; Contreras M; Orsi M
    Arch Argent Pediatr; 2017 Dec; 115(6):533-540. PubMed ID: 29087106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Fedor I; Zold E; Barta Z
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries.
    Dalzell AM; Ba'Ath ME
    Paediatr Int Child Health; 2019 Feb; 39(1):48-58. PubMed ID: 30900526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant advantages for first line treatment with TNF-alpha inhibitors in pediatric patients with inflammatory bowel disease - Data from the multicenter CEDATA-GPGE registry study.
    Claßen M; de Laffolie J; Claßen M; Schnell A; Sohrabi K; Hoerning A
    Front Pediatr; 2022; 10():903677. PubMed ID: 36304532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.